Atlas Trials

A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer

Clinical trial NCT05385809 · UNKNOWN

Trial details

NCT number
NCT05385809
Sponsor
Zhejiang Cancer Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Unresectable Gastric Cancer
Start date
2022-06-01
Primary completion
2022-07-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.